Anavex Life Sciences Corp. (NASDAQ:AVXL – Get Rating) has been given a consensus rating of “Buy” by the seven research firms that are currently covering the company, Marketbeat reports. One equities research analyst has rated the stock with a sell recommendation and six have assigned a buy recommendation to the company. The average twelve-month price […]
Wall Street brokerages expect Anavex Life Sciences Corp. (NASDAQ:AVXL – Get Rating) to announce ($0.16) earnings per share (EPS) for the current fiscal quarter, Zacks Investment Research reports. Zero analysts have made estimates for Anavex Life Sciences’ earnings. Anavex Life Sciences posted earnings of ($0.14) per share during the same quarter last year, which indicates […]
Anavex Life Sciences (NASDAQ:AVXL – Get Rating) was downgraded by Zacks Investment Research from a “buy” rating to a “hold” rating in a report released on Tuesday, Zacks.com reports. According to Zacks, “ANAVEX LIFE SCIENCES CORP. is an emerging biopharmaceutical company engaged in the discovery and development of novel drug targets for the treatment of […]
Anavex Life Sciences (NASDAQ:AVXL – Get Rating) and Kodiak Sciences (NASDAQ:KOD – Get Rating) are both small-cap medical companies, but which is the better business? We will compare the two businesses based on the strength of their analyst recommendations, valuation, profitability, risk, dividends, earnings and institutional ownership. Earnings & Valuation This table compares Anavex Life […]